Your account is not claimed yet. You can sign up with ORCID to claim your account.

Camelia Bucșa (Camelia Bucsa)

Years Active: 2018-2022
Publications (10 Years): 5

Iuliu Hațieganu University of Medicine and Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Iuliu Hațieganu University of Medicine and Pharmacy

Romania

researcher :: Drug Information Research Center

Publications

Noémi-Beátrix Bulik, Andreea Farcas, Camelia Bucșa, Irina Iaru, Ovidiu Oniga
Safety of Antibiotics in Hospitalized Children in Romania: A Prospective Observational Study. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Ioana Frent, Camelia Bucșa, Daniel Leucuta, Andreea Farcas, Cristina Mogosan
An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: A VigiBase study. Pharmacoepidemiology and drug safety 30 (10) (2021)
Mariana Sipos, Andreea Farcas, Daniel-Corneliu Leucuta, Camelia Bucșa, Madalina Huruba, Cristina Ionela Mogoșan
Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Andreea Farcas, Teodora Balcescu, Laura Anghel, Camelia Bucșa, Cristina Mogoșan
A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012. Expert opinion on drug safety 19 (6) (2020)
Andreea Farcas, Noemi Beatrix Bulik, Andreea Popa, Agatha Mensah Achampong, Camelia Bucșa, Cristina Mogosan
Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting. European journal of clinical pharmacology 75 (3) (2018)

Camelia Bucșa.css-eqlu8i{font-size:small;padding-left:4px;} (Camelia Bucsa)